Alpha Healthcare Acquisit... (ALPAU)
NASDAQ: ALPAU
· Real-Time Price · USD
9.75
0.31 (3.28%)
At close: Jul 14, 2023, 4:09 PM
Alpha Healthcare Acquisition III Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Revenue | -3.19M | 32.84K | 3.76M | 3.74M | 3.73M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 1.79M | 3.09M | 1.55M | 1.54M | 1.54M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -1.89M | 27.71K | 2.21M | 2.2M | 2.18M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | 1.29M | -2.35M | -7.75M | -7.09M | -6.72M | -1.87M | -1.65M | -1.41M | -1.38M | -1.1M | -563.75K | -96.32K | -6.37K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 918.23K | -9.04M | -17.65M | -13.85M | -9.34M | 2.04M | 596.2K | -363.08K | -1.02M | -950.58K | -423.05K | -93.67K | -6.37K |
Net Income | 1.7M | -8.31M | -17.7M | -14.24M | -9.86M | 1.31M | 205K | -225.03K | -1.15M | -809.88K | -282.35K | -91.02K | -6.37K |
Selling & General & Admin | 9.2M | 12.14M | 6.66M | 6.33M | 6.08M | 1.87M | 1.65M | 1.41M | 1.38M | 1.09M | 557.39K | 89.96K | n/a |
Research & Development | 2.21M | 3.69M | 2.11M | 1.78M | 1.67M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 36.38K | 36.38K | 36.38K | 23.24K | n/a | n/a | n/a | n/a | n/a | -6.37K | -6.37K | -6.37K | -6.37K |
Operating Expenses | 11.46M | 15.87M | 8.8M | 8.13M | 7.75M | 1.87M | 1.65M | 1.41M | 1.38M | 1.09M | 551.02K | 83.59K | -6.37K |
Interest Expense | -34.21K | -99.83K | -76.02K | -68.89K | -65.63K | n/a | n/a | -138.05K | -140.7K | -140.7K | -140.7K | -2.65K | n/a |
Selling & Marketing Expenses | -2.66M | 131.11K | 3.2M | 3.08M | 3.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 13.24M | 18.96M | 10.35M | 9.67M | 9.3M | 1.87M | 1.65M | 1.41M | 1.38M | 1.09M | 551.02K | 83.59K | -6.37K |
Income Tax Expense | -783.9K | -734.53K | 49.38K | 392.71K | 517.5K | 734.53K | 391.2K | -138.05K | 125.7K | -140.7K | -140.7K | -2.65K | n/a |
Shares Outstanding (Basic) | 20.91M | 20.91M | 20.91M | 20.74M | 18.63M | 15.44M | 15.44M | 15.44M | 15.44M | n/a | n/a | n/a | 15.44M |
Shares Outstanding (Diluted) | 20.91M | 20.91M | 20.91M | 20.74M | 18.63M | 15.44M | 15.44M | 3.86M | 3.86M | n/a | n/a | n/a | n/a |
EPS (Basic) | 0.16 | -0.39 | -0.92 | -0.7 | -0.49 | 0.11 | 0.03 | -0.03 | -0.07 | -0.05 | -0.05 | -0.00 | -0.00 |
EPS (Diluted) | -0.09 | -0.64 | -0.92 | -0.45 | -0.24 | 0.29 | -0.04 | -0.1 | -0.14 | -0.05 | -0.05 | n/a | n/a |
EBITDA | 7.75M | -1.87M | -13.67M | -14.7M | -16.4M | -5.79M | -3.9M | -2.19M | -1.46M | -971.11K | -428.36K | -98.97K | -6.37K |
EBIT | 7.41M | -2.61M | -14.14M | -13.48M | -13.65M | -2.41M | -2.18M | -1.95M | -1.38M | -1.09M | -557.39K | -89.96K | n/a |
Depreciation & Amortization | 3.28M | 3.69M | 470.99K | -1.22M | -3.28M | -3.92M | -2.25M | -773.14K | -77.51K | 183.59K | 191.2K | 53.15K | 55.81K |